A furious row has broken out between a drugs company and the NHS regulator in England over the price of a new breast cancer treatment.
Kadcyal which is manufactured by Roche Products Limited can give patients with HER2-positive breast cancer an additional six months of life, but the regulator deemed it too expensive.
ITV News correspondent Nina Nannar reports.
More top news
A man who helped officers apprehend a suspected drug dealer by sticking out his foot and tripping him has been hailed a "legend" by police.
Sarah Bartlett was surprised when she received an anonymous card containing £100 as a reward for doing an "amazing job" as a mum
A cat who prowls a station on the hunt for mice has been promoted to become the official pest control manager.